Apolipoprotein E and intellectual achievement

Journal of the American Geriatrics Society

Volumn 50, Issue 1, 2002, Pages 49-54

  Caselli, Richard J ^a   Hentz, Joseph G ^a   Osborne, David ^a   Graff Radford, Neill R ^a   Barbieri, Carolyn J ^a   Alexander, Gene E ^a,b   Hall, Geri R ^a   Reiman, Eric M ^a,c,d   Hardy, John ^a   Saunders, Ann M ^e  

^a MAYO CLINIC   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; Apolipoprotein E; Intelligence

Indexed keywords

APOLIPOPROTEIN E;

ACADEMIC ACHIEVEMENT; ADULT; AGED; ARTICLE; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; SCORING SYSTEM;

APOLIPOPROTEINS E; ARIZONA; EDUCATIONAL STATUS; FEMALE; HOMOZYGOTE; HUMANS; INCOME; INTELLIGENCE; INTELLIGENCE TESTS; MALE; OCCUPATIONS;

EID: 0036143871     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50007.x     Document Type: Article

References (49)

1. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life: Findings from the Nun study
2. Childhood mental ability and dementia
3. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
4. Association of apolipoprotein E allele ε4 with late onset familial and sporadic Alzheimer's disease
5. Neuropathology of preclinical and clinical late onset Alzheimer's disease
6. High frequency of apolipoprotein E e4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes
7. Preclinical evidence of Alzheimer's diease in persons homozygous for the e4 allele for apolipoprotein E
8. Preclinical memory decline in cognitively normal apolipoprotein E-e4 homozygotes
9. Preclinical evidence of Alzheimer's disease in persons heterozygous for the epsilon 4 allele for apolipoprotein E
10. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease
11. Patterns of brain activation in people at risk for Alzheimer's disease
12. ApoE as a prognostic factor for post traumatic coma
13. Apolipoprotein E e4 associated with chronic traumatic brain injury in boxing
14. Apolipoprotein E-e4 genotype predicts a poor outcome in survivors of traumatic brain injury
15. ApoE genotype and survival from intracerebral hemorrhage
16. The apolipoprotein E e4 allele and outcome in cerebrovascular disease
17. Intracerebral hemorrhage outcome: APOE, hematoma and edema volumes
18. The role of apolipoprotein E in Alzheimer's disease, acute brain injury, and cerebrovascular disease: Evidence of common mechanisms and utility of animal models
19. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol of the extension of neurites by rabbit dorsal root ganglion neurons in vitro
20. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
21. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth
22. WAIS performances of brain damaged and neurotic patients
23. The intelligence quotient as an index of brain damage
24. An index of premorbid intelligence
25. Predicting the premorbid intellectual status of children using demographic data
26. A demographically based index of premorbid intelligence for the WAIS-R
27. Relationship between lifetime occupation and parietal flow
28. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: Implications for the cognitive reserve hypothesis
29. Rate of memory decline in AD is related to education and occupation: Cognitive reserve?
30. Restriction isotyping of human apolipoprotein E by gene 33. Amplification and cleavage with Hha I
31. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health work group
32. Mild cognitive impairment: Clinical characterization and outcome
33. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS/ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
34. Population-based norms for the Mini-Mental State Examination by age and education level
35. Factor index score patterns in the WAIS-III standardization sample
36. Educational attainment and socioeconomic status of patients with autopsy-confirmed Alzheimer disease
37. Age and WAIS-R intelligence in a national sample of adults in the 20- to 74-year age range: A cross sectional analysis with educational level controlled
38. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in adult rats
39. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease
40. Influence of apolipoprotein E genotype on neuronal damage and apoe immunoreactivity in human hippocampus after global ischemia
41. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins
42. Evil forces and vulnerable brains
43. Amyloid, the presenilins, and Alzheimer's disease
44. Exploring the etiology of Alzheimer's disease using molecular genetics
45. Early onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum
46. Apolipoprotein E genetic variation and Alzheimer's disease: A meta-analysis